
Emvenio Research: Enhancing clinical trial access through decentralized solutions for high-risk populations.
Emvenio Research was founded with the mission to enhance clinical trial access by developing decentralized solutions that cater to underserved and high-risk populations. The company aims to eliminate barriers to clinical trials by bringing them directly to people where they live and work. Emvenio offers a range of services including community research sites, home and virtual visits, and patient engagement strategies. Their market focus is on diverse and underserved communities, ensuring that clinical research is more inclusive and accessible.
Notable affiliated individuals include experts in clinical research and community health, though specific names are not provided. Emvenio has garnered attention for its innovative approach to decentralizing clinical trials, significantly improving participation rates among high-risk populations. The company's impact is evident in its ability to bring clinical trials to local communities, thereby increasing diversity in research and accelerating the development of new treatments.

Lightship
lightship.com

MedVector
medvector.com

Curavit Clinical Research

SiteBridge Research

ObvioHealth
obviohealth.com

Paradigm
paradigm.inc

RxE2
rxe2.com

SubjectWell
subjectwell.com

Curebase
curebase.com

Empirican Group
empirican.com

Clinical Research IO

Elligo Health Research

High Enroll
highenroll.org

FindMeCure
findmecure.com

Vitalief
vitalief.com
Companies similar to Emvenio Research include Lightship, MedVector, Curavit Clinical Research and SiteBridge Research.
Emvenio Research was founded in 2020.
Emvenio Research's headquarters is located in Durham, NC, US.
Emvenio Research's most recent funding round was for $9.2M (USD) in August 2022.
As of Aug 24, 2022, Emvenio Research has raised a total of $9.2M (USD).
Emvenio Research has 52 employees as of Feb 5, 2024.